Maternal and perinatal outcomes in pregnant women with Lassa fever: analysis from the LASCOPE prospective cohort study. // The Lancet Infectious Diseases. – URL: https://www.sciencedirect.com/science/article/pii/S1473309926005244?dgcid=rss_sd_all
Maternal and perinatal outcomes in pregnant women with Lassa fever: analysis from the LASCOPE prospective cohort study. The Lancet Infectious Diseases. https://www.sciencedirect.com/science/article/pii/S1473309926005244?dgcid=rss_sd_all
“Maternal and perinatal outcomes in pregnant women with Lassa fever: analysis from the LASCOPE prospective cohort study.” The Lancet Infectious Diseases.
@article{article68603,
title = {Maternal and perinatal outcomes in pregnant women with Lassa fever: analysis from the LASCOPE prospective cohort study},
journal = {The Lancet Infectious Diseases},
url = {https://www.sciencedirect.com/science/article/pii/S1473309926005244?dgcid=rss_sd_all}
}
ABSTRACT Background Aspergillus fumigatus can cause life‐threatening infections, primarily treated with azole antifungals. Azole‐resistant A. fumigatus (ARAF) is a major clinical concern. Environmental resistance development is an...
ABSTRACT Background The lipid‐dependent yeast genus Malassezia is composed of skin commensals that can become pathogenic. This genus can cause bloodstream infection in low‐weight preterm neonates and immunocompromised adults. However,...